73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
A AGFA-Gevaert NV
A
Closed
0.76 -3.55
Overview
Share price change
24h
Min
0.76
Max
0.769
Income | 54M 32M |
|---|---|
Sales | 39M 281M |
EPS | 0.02 |
Profit margin | 11.388 |
Employees | 4,765 |
EBITDA | 46M 43M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +65.29% upside |
Market Cap | -48M 126M |
|---|---|
Previous open | 4.31 |
Previous close | 0.76 |
AGFA-Gevaert NV Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
AGFA-Gevaert NV Forecast
Price Target
By TipRanks
65.29% upside
12 Months Forecast
Average 4 EUR 65.29%
High 4 EUR
Low 4 EUR
Based on 1 Wall Street analysts offering 12 month price targets forAGFA-Gevaert NV - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About AGFA-Gevaert NV
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company's CONOPS segment engages in supply of film and chemicals, as well support services. Its Radiology Solutions segment offers analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing software. The company's Healthcare IT segment provides healthcare's enterprise imaging platform. Its Digital Print & Chemicals segment offers inkjet printers for sign and display and packaging printing companies; inkjet inks and fluids for industrial inkjet applications, such as signs, posters and displays, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; electrolysis membranes to the hydrogen production industry, as well as for printable synthetic papers. This segment also provides films for micrography, non-destructive testing, aerial photography and printed circuit board production; membranes for green hydrogen production; and conductive polymers and materials for the production of high-security ID documents. The company sells its products through its own sales organization, as well as through a network of agents and representatives. Agfa-Gevaert NV was founded in 1867 and is headquartered in Mortsel, Belgium.
Other stocks from the sector
Live chat